Caldwell Sutter Capital »

Prelude Therapeutics shares owned by Caldwell Sutter Capital

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Caldwell Sutter Capital from 13F filings

Historical chart of Caldwell Sutter Capital investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Caldwell Sutter Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Caldwell Sutter Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.8k 2.0k 2.90

More positions owned by Caldwell Sutter Capital

Apple (AAPL)
Perma-pipe International (PPIH)
Msa Safety Inc equity (MSA)
Caterpillar (CAT)
Plumas Ban (PLBC)
Visa Com Cl A (V)
Donegal Group Cl A (DGICA)
Summit State Bank (SSBI)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathawa Inc Del Cl B New (BRK.B)
Vanguard Specialized Funds Div App Etf (VIG)
JPMorgan Chase & Co. (JPM)
Ishares Tr 0-3 Mnth Treasry (SGOV)
American Express Company (AXP)

View all positions for Caldwell Sutter Capital

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Vanguard Group
Millennium Management
Kynam Capital Management
Acadian Asset Management
Marshall Wace
Geode Capital Management
Renaissance Technologies
BlackRock
Two Sigma Advisers
Susquehanna International
TD Asset Management
Two Sigma Investments
State Street Corporation

View all funds holding Prelude Therapeutics